feed,title,long_url,short_url
Motley,Can CureVac Win Market Share With Only 48% Vaccine Efficacy?,https://www.fool.com/investing/2021/07/10/can-curevac-still-win-after-efficacy-flop/?source=iedfolrf0000001,https://j.mp/3qYPOtR
